| Dec'19 | Dec'18 | Dec'17 | Dec'16 | Dec'15 | Dec'14 | Dec'13 | Dec'12 | Dec'11 | Dec'10 |
|---|---|---|---|---|---|---|---|---|---|
Biomedical | |||||||||
- | - | - | - | - | - | - | 273 | - | - |
Revenues - Services | |||||||||
- | - | - | - | - | - | - | - | 285 | 1,741 |
Net sales and revenue | |||||||||
- | - | - | - | 2,505 | 564 | 204 | - | - | - |
Consulting | |||||||||
- | - | - | - | - | - | - | 0 | - | - |
Net sales and revenue | |||||||||
339 | 224 | 336 | 627 | - | - | - | - | - | - |
Cost of services | |||||||||
- | - | - | - | - | - | - | - | 0 | 0 |
Gross profit (loss) | |||||||||
- | - | - | - | - | - | - | - | 285 | 1,741 |
Operating expenses: | |||||||||
Cost of sales | |||||||||
62 | 135 | 162 | 860 | - | - | - | - | - | - |
Cost of sales | |||||||||
- | - | - | - | 1,880 | 242 | 296 | - | - | - |
Biomedical cost of sales | |||||||||
- | - | - | - | - | - | - | 194 | - | - |
Consulting operating expenses | |||||||||
- | - | - | - | - | - | - | 0 | - | - |
General and administrative | |||||||||
13,458 | 13,220 | 12,780 | 11,670 | 13,068 | 7,875 | 9,162 | 3,455 | 1,219 | 1,328 |
Selling and marketing | |||||||||
141 | 308 | 360 | 425 | 709 | 314 | 58 | 471 | 102 | 102 |
Research and development | |||||||||
37,669 | 24,150 | 14,609 | 11,475 | 7,573 | 3,146 | 2,041 | 3,214 | - | - |
Impairment of investments | |||||||||
0 | 2,914 | 0 | 4,611 | 123 | 1,427 | 0 | - | - | - |
Impairment on non-current assets | |||||||||
- | - | - | - | - | - | - | 0 | - | - |
Total operating expenses | |||||||||
51,332 | 40,730 | 27,913 | 29,043 | 23,354 | 13,006 | 11,558 | 7,335 | 1,322 | 1,430 |
Operating loss | |||||||||
-50,992 | -40,505 | -27,576 | -28,415 | -20,848 | -12,442 | -11,353 | -7,061 | -1,036 | 311 |
Other (expense) income: | |||||||||
Interest expense | |||||||||
- | - | - | - | - | - | - | 0 | 9 | 486 |
Interest income, net | |||||||||
809 | 392 | 133 | 78 | 42 | 15 | 1 | 1 | - | - |
Gain (loss) on settlement of debt | |||||||||
- | - | - | - | - | - | - | - | 52 | 0 |
Other expense, net | |||||||||
199 | 1,172 | 1,955 | 132 | 630 | 71 | -6 | 28 | 477 | 0 |
Total other (expense) income | |||||||||
1,009 | 1,565 | 2,088 | 211 | 672 | 87 | -4 | 30 | 520 | -486 |
Loss before taxes | |||||||||
-49,983 | -38,940 | -25,487 | -28,204 | -20,176 | -12,355 | -11,358 | -7,031 | -516 | -174 |
Income taxes provision | |||||||||
1 | 4 | 2 | 4 | -728 | 0 | 0 | 0 | 0 | 0 |
Loss from continuing operations | |||||||||
- | - | - | - | - | -12,355 | -11,358 | - | - | - |
Loss on discontinued operations, net of taxes | |||||||||
- | - | - | - | - | -3,119 | -2,438 | - | - | - |
Loss on discontinued operations, net of taxes | |||||||||
- | - | - | - | - | - | - | - | -516 | -174 |
Net loss | |||||||||
-49,984 | -38,945 | -25,490 | -28,208 | -19,447 | -15,474 | -13,797 | -7,031 | -516 | -174 |
Other comprehensive loss: | |||||||||
Cumulative translation adjustment | |||||||||
8 | -1,079 | 967 | -743 | -307 | 15 | 78 | 13 | - | - |
Unrealized loss on investments, net of tax | |||||||||
0 | 0 | -240 | 5,300 | -1,376 | 1,611 | -198 | 0 | -172 | 0 |
Reclassification adjustments, net of tax, in connection with other-than-temporary impairment of investments | |||||||||
- | - | - | 5,557 | 0 | 0 | - | - | - | - |
Total other comprehensive loss | |||||||||
8 | -1,079 | 727 | -1,000 | -1,684 | 1,626 | -119 | - | - | - |
Comprehensive loss | |||||||||
-49,975 | -40,025 | -24,763 | -29,208 | -21,132 | -13,848 | -13,916 | -7,017 | -689 | -174 |
Basic | |||||||||
- | - | - | - | - | -1.43 | -1.96 | - | - | - |
Diluted | |||||||||
- | - | - | - | - | -1.43 | -1.96 | - | - | - |
Basic | |||||||||
- | - | - | - | - | -0.36 | -0.42 | - | - | - |
Diluted | |||||||||
- | - | - | - | - | -0.36 | -0.42 | - | - | - |
Net loss per share: | |||||||||
Basic | |||||||||
- | - | - | - | -1.70 | -1.79 | -2.38 | -2.24 | - | - |
Diluted | |||||||||
- | - | - | - | -1.70 | -1.79 | -2.38 | -2.24 | - | - |
Basic and diluted | |||||||||
-2.63 | -2.20 | -1.78 | -2.09 | - | - | - | - | 0.00 | 0.00 |
Weighted average common shares outstanding: | |||||||||
Basic | |||||||||
- | - | - | - | 11,472 | 8,627 | 5,792 | 3,134 | - | - |
Diluted | |||||||||
- | - | - | - | 11,472 | 8,627 | 5,792 | 3,134 | - | - |
Basic and diluted | |||||||||
18,983 | 17,741 | 14,345 | 13,507 | - | - | - | - | - | - |
Basic and diluted: | |||||||||
- | - | - | - | - | - | - | - | 152,161 | 146,351 |